Clinical Trial Update: A Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Volrustomig in women with high-risk locally advanced cervical cancer (IVOLGA). The study is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Volrustomig

Snippet

Sponsor: AstraZeneca | Conditions: Locally Advanced Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING